LATEST NEWS
SUNSHINE BIOPHARMA RECEIVES SECOND TRANCHE FROM PREVIOUSLY ANNOUNCED $2,000,000 + FINANCING FOR CORONAVIRUS TREATMENT
For Immediate Release October 26, 2020 Montreal, Quebec, Canada — (ACCESSWIRE) — Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology…
CEO of Sunshine Biopharma, Dr. Steve Slilaty, is Featured on The Stock Day Podcast
Phoenix, October 22nd, 2020 (Newsfile Corp.) — The Stock Day Podcast welcomed Sunshine Biopharma (SBFM) (“the Company”), a company working on the development of a treatment for COVID-19, as well…
SUNSHINE BIOPHARMA AND UNIVERSITY OF GEORGIA TEAM UP TO DEVELOP A NEW ANTI-CORONAVIRUS DRUG
For Immediate Release October 19, 2020 Montreal, Canada – (ACCESSWIRE) – Sunshine Biopharma Inc. (OTC Markets: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and…
